Scientists have developed a bioengineered chewing gum that reduces HPV levels by up to 93% and nearly eliminates bacteria associated with head and neck cancer. By selectively targeting harmful pathogens while preserving beneficial oral microbes, this innovation offers a safer and more affordable therapeutic option.